NO173318C - T!rt, styrkestabilisert, partikkelformet, lettstr!mmende tocoferolpreparat - Google Patents

T!rt, styrkestabilisert, partikkelformet, lettstr!mmende tocoferolpreparat

Info

Publication number
NO173318C
NO173318C NO870159A NO870159A NO173318C NO 173318 C NO173318 C NO 173318C NO 870159 A NO870159 A NO 870159A NO 870159 A NO870159 A NO 870159A NO 173318 C NO173318 C NO 173318C
Authority
NO
Norway
Prior art keywords
particulate
dry
flowing
stabilized
strength
Prior art date
Application number
NO870159A
Other languages
English (en)
Other versions
NO870159L (no
NO870159D0 (no
NO173318B (no
Inventor
Bruce E Wenzel
James P Clark
Original Assignee
Henkel Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Corp filed Critical Henkel Corp
Publication of NO870159D0 publication Critical patent/NO870159D0/no
Publication of NO870159L publication Critical patent/NO870159L/no
Publication of NO173318B publication Critical patent/NO173318B/no
Publication of NO173318C publication Critical patent/NO173318C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrane Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
NO870159A 1986-01-16 1987-01-15 T!rt, styrkestabilisert, partikkelformet, lettstr!mmende tocoferolpreparat NO173318C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/819,779 US4711894A (en) 1986-01-16 1986-01-16 Stabilized tocopherol in dry, particulate, free-flowing form

Publications (4)

Publication Number Publication Date
NO870159D0 NO870159D0 (no) 1987-01-15
NO870159L NO870159L (no) 1987-07-17
NO173318B NO173318B (no) 1993-08-23
NO173318C true NO173318C (no) 1993-12-01

Family

ID=25229038

Family Applications (1)

Application Number Title Priority Date Filing Date
NO870159A NO173318C (no) 1986-01-16 1987-01-15 T!rt, styrkestabilisert, partikkelformet, lettstr!mmende tocoferolpreparat

Country Status (9)

Country Link
US (1) US4711894A (no)
EP (1) EP0229652B1 (no)
JP (1) JP2677554B2 (no)
AT (1) ATE68971T1 (no)
DE (1) DE3774137D1 (no)
DK (1) DK169230B1 (no)
ES (1) ES2026851T3 (no)
FI (1) FI87524C (no)
NO (1) NO173318C (no)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3820693A1 (de) * 1988-06-18 1989-12-21 Henkel Kgaa Topische kosmetische und pharmazeutische zubereitungen
US5120761A (en) * 1988-10-14 1992-06-09 Finnan Jeffrey L Method of making a free-flowing spray dried edible powder comprising an oil
FI901046A7 (fi) * 1989-03-17 1990-09-18 Eisai Co Ltd Polyprenyyliyhdisteen stabiloiminen
EP0476156B1 (en) * 1990-04-06 1996-08-07 Eisai Co., Ltd. Solid oral preparation containing catechol compound
US5234695A (en) * 1990-07-24 1993-08-10 Eastman Kodak Company Water dispersible vitamin E composition
US6020003A (en) * 1998-02-23 2000-02-01 Basf Corporation Method of making spray-dried powders with high edible-oil loadings based on non-hydrolyzed gelatin
US6613821B2 (en) * 1998-10-09 2003-09-02 Canon Kabushiki Kaisha Cloth treating agent, cloth, textile printing process and print
US6303167B1 (en) * 1998-11-09 2001-10-16 Archer-Daniels-Midland Company Method of producing vitamin powders
US6716451B1 (en) * 1999-11-30 2004-04-06 Soft Gel Technologies, Inc. Formulation and delivery method to enhance antioxidant potency of vitamin E
GB0017060D0 (en) * 2000-07-11 2000-08-30 Hunter Fleming Ltd Production, stabilisation and use of reduced forms of pharmaceutical compounds
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
US7329688B2 (en) * 2002-12-17 2008-02-12 Soft Gel Technologies, Inc. Natural vitamin E compositions with superior antioxidant potency
DE10311585A1 (de) * 2003-03-14 2004-09-23 Basf Ag Wirkstoffhaltige Adsorbate
US20070237834A1 (en) * 2003-04-18 2007-10-11 Bioderm Research Zinc Zeolite for the Treatment for Diaper Rash (Diaper Dermatitis)
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE102004032051A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
US9247765B2 (en) 2004-01-14 2016-02-02 Omniactive Health Technologies Limited Stable beadlets of lipophilic nutrients
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
WO2007074043A1 (de) * 2005-12-22 2007-07-05 Basf Se Verfahren zur herstellung von vitamin e-adsorbaten
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
KR101616246B1 (ko) 2008-01-25 2016-05-02 그뤼넨탈 게엠베하 약제학적 투여형
AU2009243681B2 (en) 2008-05-09 2013-12-19 Grunenthal Gmbh Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
WO2011009602A1 (en) 2009-07-22 2011-01-27 Grünenthal GmbH Hot-melt extruded controlled release dosage form
TWI473628B (zh) * 2009-07-22 2015-02-21 用於對氧化敏感之類鴉片藥劑之抗破壞劑型
US9579285B2 (en) 2010-02-03 2017-02-28 Gruenenthal Gmbh Preparation of a powdery pharmaceutical composition by means of an extruder
WO2012028318A1 (en) 2010-09-02 2012-03-08 Grünenthal GmbH Tamper resistant dosage form comprising an anionic polymer
CA2808219C (en) 2010-09-02 2019-05-14 Gruenenthal Gmbh Tamper resistant dosage form comprising inorganic salt
ES2648129T3 (es) 2011-07-29 2017-12-28 Grünenthal GmbH Pastilla a prueba de manipulación que proporciona una liberación inmediata de un medicamento
AU2012289764B2 (en) 2011-07-29 2017-03-02 Grünenthal GmbH Tamper-resistant tablet providing immediate drug release
US20130225697A1 (en) 2012-02-28 2013-08-29 Grunenthal Gmbh Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
PL2838512T3 (pl) 2012-04-18 2018-12-31 Grünenthal GmbH Farmaceutyczna postać dawkowania odporna na niewłaściwe użycie i odporna na uderzeniowe uwalnianie dawki
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
AU2014273227B2 (en) 2013-05-29 2019-08-15 Grunenthal Gmbh Tamper-resistant dosage form containing one or more particles
JP6466417B2 (ja) 2013-05-29 2019-02-06 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 二峰性放出プロファイルを有する改変防止（ｔａｍｐｅｒ−ｒｅｓｉｓｔａｎｔ）剤形
JP6449871B2 (ja) 2013-07-12 2019-01-09 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング エチレン−酢酸ビニルポリマーを含有する改変防止剤形
EP3073994A1 (en) 2013-11-26 2016-10-05 Grünenthal GmbH Preparation of a powdery pharmaceutical composition by means of cryo-milling
EP3142646A1 (en) 2014-05-12 2017-03-22 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
EA201692388A1 (ru) 2014-05-26 2017-05-31 Грюненталь Гмбх Лекарственная форма в виде множества частиц, защищенная от вызываемого этанолом сброса дозы
BR112017021475A2 (pt) 2015-04-24 2018-07-10 Gruenenthal Gmbh forma de dosagem resistente à adulteração (tamper) com liberação imediata e resistência contra extração de solvente
WO2017042325A1 (en) 2015-09-10 2017-03-16 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3608083A (en) * 1968-06-05 1971-09-21 Hoffmann La Roche Vitamin e powder
US3655852A (en) * 1969-08-01 1972-04-11 Hoffmann La Roche Method of forming a stable vitamin e-c granulation
GB1444024A (en) 1973-07-20 1976-07-28 Passwaterr A Food and feed supplents
FR2244468A1 (en) * 1973-07-31 1975-04-18 Passwater Richard Anticarcinogenic food supplements - contg antioxidants and S-contg amino acids
US3873694A (en) * 1973-09-27 1975-03-25 Cpc International Inc Direct compression tabletting composition and pharmaceutical tablets produced therefrom
JPS5421403B2 (no) * 1974-01-18 1979-07-30
JPS53148546A (en) * 1977-05-31 1978-12-25 Asahi Denka Kogyo Kk Cosmetic base composition
JPS56164749A (en) * 1980-05-22 1981-12-17 Chubu Shiryo Kk Breeding method of livestock
US4395422A (en) * 1981-04-06 1983-07-26 Basf Wyandotte Corporation Spray dried vitamin E powder
DE3372703D1 (en) * 1982-10-29 1987-09-03 Crinos Industria Farmaco Cosmetic preparations promoting the trophism of the skin and of the related hair follicles
JPS6025918A (ja) * 1983-07-25 1985-02-08 Ajinomoto Co Inc 脂溶性薬物含有水性液

Also Published As

Publication number Publication date
DK25587D0 (da) 1987-01-16
FI87524B (fi) 1992-10-15
ATE68971T1 (de) 1991-11-15
JPS62190181A (ja) 1987-08-20
FI87524C (fi) 1993-01-25
NO870159L (no) 1987-07-17
NO870159D0 (no) 1987-01-15
JP2677554B2 (ja) 1997-11-17
ES2026851T3 (es) 1992-05-16
FI870169A0 (fi) 1987-01-16
NO173318B (no) 1993-08-23
FI870169L (fi) 1987-07-17
DE3774137D1 (de) 1991-12-05
DK169230B1 (da) 1994-09-19
DK25587A (da) 1987-07-17
EP0229652B1 (en) 1991-10-30
US4711894A (en) 1987-12-08
EP0229652A2 (en) 1987-07-22
EP0229652A3 (en) 1987-10-14

Similar Documents

Publication Publication Date Title
NO173318C (no) T!rt, styrkestabilisert, partikkelformet, lettstr!mmende tocoferolpreparat
ES2072959T3 (es) Derivados de aminoacido.
NO843002L (no) Vandig loesning inneholdende en lipid-loeselig farmasoeytisk substans
DK581185D0 (da) Farmaceutisk praeparat indeholdende 13-cis-a-vitaminsyre
ATE81135T1 (de) Aktive thymopentin-analoga.
DK605786A (da) Stabiliserede human-vaevsplasminogenaktivator-praeparater
DE3853922D1 (de) Aminosäurederivate als Amphotere.
NO890921D0 (no) Fremgangsmaate for fremstilling av aminosyrederivater.
FI822414A0 (fi) Syror av n-substituerade 2-pyrrolidon-4-karboxylsyror som befuktningsmedel
DK77490A (da) Substituerede arylurinstofderivater, deres fremstilling og anvendelse som soedemidler
DK156053C (da) S-(carbamoyl-phenylselenyl)-derivater af glutathion og af alfa-aminomercaptocarboxylsyrer, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse
DE3787657D1 (de) Aminosäure-Derivate.
NO863373D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyre derivater.
FI883338A0 (fi) Vattenloesningar av doxorubicinhydroklorid.
SE7904284L (sv) Farmaceutiska beredningar som innehaller prostaglandiner samt forfarande for framstellning av dem
NO884005D0 (no) Fluorerte derivater av aminosyrer saerlig for bruk som oveflateaktive midler.
ATE130009T1 (de) Antitumor-aminosäuren und peptid-derivate von 1,4-bis((aminoalkyl und hydroxyaminoalkyl)amino>5,8- dihydroxyanthraquinonen.
ATE103178T1 (de) T-pa pro stabilisierung.
RU1797460C (ru) Нематоцидное средство
KR900700471A (ko) 신규의 2,3-티오모르폴린디온-2-옥심유도체, 이들을 함유하는 약제학적 조성물 및 제법
ZA854708B (en) S-(carbamoylphenylselenyl)derivatives of glutathione and of aminomercaptocarboxylic acids,processes for their preparation and pharmaceutical preparations containing them
JPS57170151A (en) Feed for mulberry silkworm
ATE95518T1 (de) Aminosaeure-derivate.
IT8522278V0 (it) Struttura di gemelli particolarmente per polsini di camicie.
NO883164L (no) Forsterkende gamma-karboksylering av rekombinant vitamin k - avhengige proteiner.